The c-Myc target gene network

Cited by (1,000)

Items 101–200 of 1,000

1. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
   Verónica Rodríguez-Bravo, Raffaella Pippa, Won-Min Song, Marc Carceles‐Cordon, Ana Dominguez-Andres, Naoto Fujiwara, JungReem Woo, Anna P. Koh, Adam Ertel, Ravi K. Lokareddy et al. · 2018 · Cell
2. Programming inactive RNA-binding small molecules into bioactive degraders
   Yuquan Tong, Yeongju Lee, Xiaohui Liu, Jessica L. Childs‐Disney, Blessy M. Suresh, Raphael I. Benhamou, Chunying Yang, Weimin Li, Matthew G. Costales, Hafeez S. Haniff et al. · 2023 · Nature
3. Polyamine synthesis as a target of MYC oncogenes
   André S. Bachmann, Dirk Geerts · 2018 · Journal of Biological Chemistry
4. Cdc45 Is a Critical Effector of Myc-Dependent DNA Replication Stress
   Seetha V. Srinivasan, David Dominguez-Sola, Lily C. Wang, Olivier Hyrien, Jean Gautier · 2013 · Cell Reports
5. Sfp1 Interaction with TORC1 and Mrs6 Reveals Feedback Regulation on TOR Signaling
   Harri Lempiäinen, Aino Uotila, Jörg Urban, Ilse Dohnal, Gustav Ammerer, Robbie Loewith, David Shore · 2009 · Molecular Cell
6. The Myc Transactivation Domain Promotes Global Phosphorylation of the RNA Polymerase II Carboxy-Terminal Domain Independently of Direct DNA Binding
   Victoria H. Cowling, Michael D. Cole · 2007 · Molecular and Cellular Biology
7. EZH2, an epigenetic driver of prostate cancer
   Yeqing Angela Yang, Jindan Yu · 2013 · Protein & Cell
8. Myc Goes Global: New Tricks for an Old Oncogene
   Paul S. Knoepfler · 2007 · Cancer Research
9. Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells
   Bum-Kyu Lee, Akshay Bhinge, Anna Battenhouse, R. M. McDaniell, Zheng Liu, Lingyun Song, 运运 倪, Ewan Birney, Jason D. Lieb, Terrence S. Furey et al. · 2011 · Genome Research
10. Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
    Daniel Massó-Vallés, Laura Soucek · 2020 · Cells
11. Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells
    Guosheng Wu, Jin‐Jian Lu, Jia-Jie Guo, Ying‐Bo Li, Wen Tan, Yuanye Dang, Zhangfeng Zhong, Zengtao Xu, Xiuping Chen, Yitao Wang · 2011 · Fitoterapia
12. Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
    Megan R. Doe, Janice M. Ascano, Mandeep Kaur, Michael D. Cole · 2011 · Cancer Research
13. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
    R. Brooks Robey, Judith Weisz, Nancy B. Kuemmerle, Anna C. Salzberg, Arthur S Berg, Dustin G. Brown, Laura L. Maurer, Roberta Palorini, Fahd Al‐Mulla, Rabeah Abbas Al-Temaimi et al. · 2015 · Carcinogenesis
14. Targeting c-Myc as a novel approach for hepatocellular carcinoma
    Che-Pin Lin, Chien-Ru Liu, Chun-Nin Lee, Tze‐Sian Chan, H Eugene Liu · 2010 · World Journal of Hepatology
15. HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc
    Yinghui Li, Zhen Wang, Hui Shi, Hang Li, Leilei Li, Runping Fang, Xiaoli Cai, Bowen Liu, Xiaodong Zhang, Lihong Ye · 2016 · Cancer Research
16. MYCN-regulated microRNAs repress estrogen receptor-α ( ESR1 ) expression and neuronal differentiation in human neuroblastoma
    Jakob Lovén, Nikolay Zinin, Therese Wahlström, Inga Müller, Petter Brodin, Erik Fredlund, Ulf Ribacke, Andor Pivarcsi, Sven Påhlman, Marie Arsenian‐Henriksson · 2010 · Proceedings of the National Academy of Sciences
17. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
    Hongyu Liu, Chuanbing Zang, Anna Emde, Maricarmen D. Planas-Silva, Marleen Rosche, Andrea Kühnl, Carsten‐Oliver Schulz, Elena Elstner, Kurt Possinger, Jan Eucker · 2008 · European Journal of Pharmacology
18. N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription Factor
    Rebecca F. Cotterman, Victor X. Jin, Sheryl R. Krig, Jessica M. Lemen, Alice Wey, Peggy Farnham, Paul S. Knoepfler · 2008 · Cancer Research
19. Mitochondria as a Potential Regulator of Myogenesis
    Akira Wagatsuma, Kunihiro Sakuma · 2013 · The Scientific World JOURNAL
20. MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
    Amy K. Schulze, Masanori Oshi, Itaru Endo, Kazuaki Takabe · 2020 · International Journal of Molecular Sciences
21. The Interplay Between MYC and HIF in the Warburg Effect
    Chi Van Dang · 2008 · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings
22. MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells
    Tsuyoshi Iwata, Denise Schultz, Jessica L Hicks, Gretchen K. Hubbard, Laura N. Mutton, Tamara Levin Lotan, Carlise R. Bethel, Matthew T. Lotz, Srinivasan Yegnasubramanian, William G. Nelson et al. · 2010 · PLoS ONE
23. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
    Sai-Wen Tang, Wen-Hsin Chang, Yih-Ching Su, Yu‐Chi Chen, Yen-Han Lai, Pei-Tzu Wu, Chyong‐Ing Hsu, Wei‐Chou Lin, Ming‐Kuen Lai, Jung‐Yaw Lin · 2008 · Cancer Letters
24. Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer
    Youxue Zhang, Lei Yao, Xianyu Zhang, Hongfei Ji, Lihong Wang, Shanshan Sun, Da Pang · 2011 · Journal of Cancer Research and Clinical Oncology
25. The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc
    Jianyong Liu, Heather J. Martin, Gangling Liao, S. Diane Hayward · 2007 · Journal of Virology
26. Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels
    Simone Buraschi, Nutan Pal, Nadia Tyler-Rubinstein, Rick T. Owens, Thomas Neill, Renato V. Iozzo · 2010 · Journal of Biological Chemistry
27. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
    Iwona Włodarska, Daan Dierickx, Vera Vanhentenrijk, Katrien Van Roosbroeck, H Pospíšilová, Francesca Minnei, Gregor E. G. Verhoef, José Thomas, Peter Vandenberghe, Chris De Wolf‐Peeters · 2008 · Blood
28. Mitochondrial Structure, Function and Dynamics Are Temporally Controlled by c-Myc
    J. Anthony Graves, Yudong Wang, Sunder Sims‐Lucas, Edward Cherok, Kristi D. Rothermund, Maria F. Branca, Jennifer D. Elster, Donna Beer–Stolz, Bennett Van Houten, Jerry E. Vockley et al. · 2012 · PLoS ONE
29. LncRNA‐MIF, a c‐Myc‐activated long non‐coding RNA, suppresses glycolysis by promoting Fbxw7‐mediated c‐Myc degradation
    Pengfei Zhang, Limian Cao, Pingsheng Fan, Yide Mei, Mian Wu · 2016 · EMBO Reports
30. Myc and its interactors take shape
    William B. Tu, Sara Helander, Robert Pilstål, K. Ashley Hickman, Corey Lourenco, Igor Jurišica, Brian Raught, Björn Wallner, Maria Sunnerhagen, Linda Z. Penn · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
31. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1
    Yue Guo, Limin Shu, Chengyue Zhang, Zheng‐Yuan Su, Ah‐Ng Tony Kong · 2015 · Biochemical Pharmacology
32. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
    Kenneth M. Felsenstein, Lindsey B. Saunders, John K. Simmons, Elena C. Leon, David R. Calabrese, Shuling Zhang, Aleksandra M. Michalowski, Peter C. Gareiss, Beverly A. Mock, John S. Schneekloth · 2015 · ACS Chemical Biology
33. Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction
    Long, Yan, Tsai, Wen-Bin, Wangpaichitr, Medhi, Tsukamoto, Takashi, Savaraj, Niramol, Feun, Lynn G., Kuo, Macus Tien · 2013 · Molecular Cancer Therapeutics
34. Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
    Ramon C. Sun, Philip G. Board, Anneke C. Blackburn · 2011 · Molecular Cancer
35. Far upstream element binding protein 1: a commander of transcription, translation and beyond
    J Zhang, Qiumin Chen · 2012 · Oncogene
36. Drugging the undruggable: Transcription therapy for cancer
    Chunhong Yan, Paul J. Higgins · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
37. BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer
    Tao Hu, Yu-Run Lu · 2015 · Cancer Cell International
38. Benzo[a]pyrene decreases global and gene specific DNA methylation during zebrafish development
    Xiefan Fang, Cammi Thornton, Brian E. Scheffler, Kristine L. Willett · 2013 · Environmental Toxicology and Pharmacology
39. Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State
    Robert J. Rounbehler, Mohammad Fallahi, Chunying Yang, Meredith A. Steeves, Weimin Li, Joanne R. Doherty, Franz X. Schaub, Sandhya Sanduja, Dan A. Dixon, Perry J. Blackshear et al. · 2012 · Cell
40. Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding
    Cecilia Andrésen, Sara Helander, Alexander S. Lemak, Christophe Farès, Veronika Csizmók, Jonas Carlsson, Linda Z. Penn, Julie Deborah Forman-Kay, C.H. Arrowsmith, Patrik Lundström et al. · 2012 · Nucleic Acids Research
41. TOR signaling in invertebrates
    Alexandre Soulard, Adiel Cohen, Michael N. Hall · 2009 · Current Opinion in Cell Biology
42. Targeted Nanoparticles Deliver siRNA to Melanoma
    Yunching Chen, Surendar Reddy Bathula, Qi Yang, Leaf Huang · 2010 · Journal of Investigative Dermatology
43. Split-luciferase complementary assay: applications, recent developments, and future perspectives
    Taha Azad, Amin Tashakor, Saman Hosseinkhani · 2014 · Analytical and Bioanalytical Chemistry
44. c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
    Yuchen Feng, Xiaoying Liu, Teng Liu, Qiang Ji, Yongyan Wu, Jinming Li, Wei Gao, Yuan Yuan Zhang, Ting La, Hessam Tabatabaee et al. · 2020 · Nature Communications
45. New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
    Eva Gottfried, Sven Arke Lang, Kathrin Renner, Anja‐Katrin Bosserhoff, Wolfram Gronwald, Michael Rehli, Sabine Einhell, Isabel Gedig, Katrin Singer, Anton Seilbeck et al. · 2013 · PLoS ONE
46. Review of Chromium (VI) Apoptosis, Cell-Cycle-Arrest, and Carcinogenesis
    Arthur O.S. Chiu, Xianglin Shi, W. K. P. LEE, Richard Hill, Timothy P. Wakeman, Alan J. Katz, Bo Xu, Naresh S. Dalal, John D. Robertson, Chao Chen et al. · 2010 · Journal of Environmental Science and Health Part C
47. Inhibition of transcription factors with small organic molecules
    Thorsten Berg · 2008 · Current Opinion in Chemical Biology
48. Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition
    Yongjun Fan, Kathleen G. Dickman, Wei‐Xing Zong · 2009 · Journal of Biological Chemistry
49. Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo
    Rajesh Kumar Gandhirajan, Peter Staib, Katharina Minke, Iris Gehrke, Günther Plickert, Axel Schlösser, Esther Katharina Schmitt, Michael J. Hallek, Karl‐Anton Kreuzer · 2010 · Neoplasia
50. Perspectives on c-Myc, Cyclin D1, and Their Interaction in Cancer Formation, Progression, and Response to Chemotherapy
    Dezhong Joshua Liao, Archana B. Thakur, Jack Wu, Hector Biliran, Fazlul H. Sarkar · 2007 · Critical Reviews™ in Oncogenesis
51. A Genome-Wide Screen for β-Catenin Binding Sites Identifies a Downstream Enhancer Element That Controls c -Myc Gene Expression
    Gregory S. Yochum, Ryan Cleland, Richard H. Goodman · 2008 · Molecular and Cellular Biology
52. MicroRNAs as regulators and mediators of c-MYC function
    René Jackstadt, Heiko Hermeking · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
53. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells
    Wakana Abe, Kaei Nasu, Chisato Nakada, Yasushi Kawano, M Moriyama, Hisashi Narahara · 2013 · Human Reproduction
54. MYU, a Target lncRNA for Wnt/c-Myc Signaling, Mediates Induction of CDK6 to Promote Cell Cycle Progression
    Yoshihiro Kawasaki, Mimon Komiya, Kosuke Matsumura, Lumi Negishi, Sakiko Suda, Masumi Okuno, Naoko Yokota, Tomoya Osada, Takeshi Nagashima, Masaya Hiyoshi et al. · 2016 · Cell Reports
55. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcriptional programs of cell proliferation and cytoprotection
    Narsa M. Reddy, Steven R. Kleeberger, Masayuki P. Yamamoto, Thomas W. Kensler, Catherine Scollick, Shyam S. Biswal, Sekhar P. Reddy · 2007 · Physiological Genomics
56. MYC and gastric adenocarcinoma carcinogenesis
    Danielle Queiroz Calcagno, Mariana Ferreira Leal, Paulo Pimentel de Assumpção, Marı́lia de Arruda Cardoso Smith, Rommel Mário Rodríguez Burbano · 2008 · World Journal of Gastroenterology
57. c-Myc Transforms Human Mammary Epithelial Cells through Repression of the Wnt Inhibitors DKK1 and SFRP1
    Victoria H. Cowling, Celina M. D’Cruz, Lewis A. Chodosh, Michael D. Cole · 2007 · Molecular and Cellular Biology
58. Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas
    Karen M. Chisholm, Charles D. Bangs, Carlos E. Bacchi, Hernan F. Molina-Kirsch, Athena M. Cherry, Yasodha Natkunam · 2015 · The American Journal of Surgical Pathology
59. MYC and Transcription Elongation
    Peter B. Rahl, R A Young · 2014 · Cold Spring Harbor Perspectives in Medicine
60. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21
    Mingfeng Zhang, Zhaoming Wang, Ofure M. Obazee, Jinping Jia, Erica J. Childs, Jason W. Hoskins, Gisella Figlioli, Evelina Mocci, Irene J. Collins, Charles C. Chung et al. · 2016 · Oncotarget
61. How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
    Martin J. Allday · 2009 · Seminars in Cancer Biology
62. Chop it, ChIP it, check it: the current status of chromatin immunoprecipitation
    Philippe Collas · 2007 · Frontiers in bioscience
63. Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
    Volkhard Seitz, Peter Butzhammer, Burkhard Hirsch, Jochen Hecht, Ines Gütgemann, Anke Ehlers, Dido Lenze, Elisabeth Oker, Anke Sommerfeld, Edda von der Wall et al. · 2011 · PLoS ONE
64. Strategically targeting MYC in cancer
    Valeriya Posternak, Michael D. Cole · 2016 · F1000Research
65. Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
    Richard J. Rebello, Richard B. Pearson, Ross D. Hannan, Luc Furic · 2017 · Genes
66. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma
    Madhulaxmi Marimuthu, Manoharan Andiappan, Abdul Wahab P U, M. R. Muthusekhar, Anandan Balakrishnan, Sambantham Shanmugam · 2018 · Indian Journal of Dental Research
67. Regulation of the PDK4 Isozyme by the Rb-E2F1 Complex
    Michael Hsieh, Debopriya Das, Nandakumar Sambandam, Michael Q. Zhang, Zaher A. Nahle · 2008 · Journal of Biological Chemistry
68. MYC in Regulating Immunity: Metabolism and Beyond
    JN Rashida Gnanaprakasam, Ruoning Wang · 2017 · Genes
69. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
    Weiping Li, Shiv Kumar Gupta, Weiguo Han, Ryan A. Kundson, Sara Nelson, Darlene L. Knutson, Patricia Theresa Greipp, Sherine F. Elsawa, Eduardo M. Sotomayor, Mamta Gupta · 2019 · Journal of Hematology & Oncology
70. Burkitt Lymphoma: Revisiting the Pathogenesis of a Virus-Associated Malignancy
    Gemma L. Kelly, Alan B. Rickinson · 2007 · Hematology
71. The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
    Lars‐Gunnar Larsson, Marie Arsenian‐Henriksson · 2010 · Experimental Cell Research
72. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth
    Marija Mihailovich, Michael Bremang, Valeria Spadotto, Daniele Musiani, Elena Vitale, Gabriele Varano, Federico Zambelli, Francesco Mattia Mancuso, David Allan Cairns, Giulio Pavesi et al. · 2015 · Nature Communications
73. The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development
    Qiang Zhang, Li Xu, Kasa Cui, Cheng Liu, Mingzhi Wu, Edward V. Prochownik, Youjun Li · 2019 · Cell Death and Differentiation
74. MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
    Erna Marija Meškytė, Sabiha Keskas, Yari Ciribilli · 2020 · International Journal of Molecular Sciences
75. Genome-Wide siRNA Screen for Modulators of Cell Death Induced by Proteasome Inhibitor Bortezomib
    Siquan Chen, Jonathan L. Blank, Theodore Peters, Xiaozhen J. Liu, David M. Rappoli, Michael D. Pickard, Saurabh Menon, Jie Yu, Denise L. Driscoll, Trupti Lingaraj et al. · 2010 · Cancer Research
76. Proteomic analysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response
    Antwoine Flowers, Harris Bell‐Temin, Ahmad Jalloh, Stanley M. Stevens, Paula C. Bickford · 2017 · Journal of Neuroinflammation
77. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.
    M. Wall, G. Poortinga, K. Hannan, R. Pearson, R. Hannan, G. McArthur · 2008 · Blood
78. c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance
    Slovénie Pyndiah, Satoshi Tanida, Kazi Mokim Ahmed, Erica K. Cassimere, Chungyoul Choe, Daitoku Sakamuro · 2011 · Science Signaling
79. Tumorigenic Development of Induced Pluripotent Stem Cells in Ischemic Mouse Brain
    Toru Yamashita, Hiromi Kawai, Fengfeng Tian, Yasuyuki Ohta, Koji Abe · 2010 · Cell Transplantation
80. Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model
    Aizea Morales‐Kastresana, Miguel F. Sanmamed, Inmaculada Rodríguez, Asís Palazón, Iván Martínez‐Forero, Sara Labiano, Sandra Hervás‐Stubbs, Bruno Sangro, Carmen Ochoa, Ana Rouzaut et al. · 2013 · Clinical Cancer Research
81. c-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, miRNAs and lincRNAs
    Wen Luo, Jiahui Chen, Limin Li, Xueyi Ren, Cheng Tian, Shiyi Lu, Raman Akinyanju Lawal, Qinghua Nie, Xiquan Zhang, Olivier Hanotte · 2018 · Cell Death and Differentiation
82. Myc's other life: stem cells and beyond
    Elisa Laurenti, Anne Wilson, Andreas Trumpp · 2009 · Current Opinion in Cell Biology
83. Epidermal Stem Cells Are Defined by Global Histone Modifications that Are Altered by Myc-Induced Differentiation
    Michaela Frye, Amanda G. Fisher, Fiona M. Watt · 2007 · PLoS ONE
84. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells
    Xiangrong Liu, Lei Wang, Shangfeng Zhao, Xunming Ji, Yumin Luo, Feng Ling · 2010 · Medical Oncology
85. SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1 through SKP2 in Human Leukemia Cells
    Gabriel Bretones, Juan Carlos Acosta, Juan M. Caraballo, Nuria Ferrándiz, María Teresa Gómez‐Casares, Marta Albajar, Rosa E. Blanco, Paula Santa Bárbara Ruiz, Wen‐Chun Hung, M. Pilar Albero et al. · 2011 · Journal of Biological Chemistry
86. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer
    Daniel Shiu‐Hin Chan, Hui Yang, Maria Hiu‐Tung Kwan, Zhen Cheng, Paul Lee, Li‐Ping Bai, Zhi‐Hong Jiang, Chun‐Yuen Wong, Wang Fun Fong, Chung‐Hang Leung et al. · 2011 · Biochimie
87. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer
    Erbao Zhang, Wei Li, Dandan Yin, Wei De, Liangjun Zhu, Sanyuan Sun, Liang Han · 2015 · Tumor Biology
88. GM-CSF Induces Inflammatory Macrophages by Regulating Glycolysis and Lipid Metabolism
    Yi Rang Na, Gyo‐Jeong Gu, Daun Jung, Young Won Kim, Juri Na, Jin Sun Woo, Joo‐Youn Cho, Hyewon Youn, Seung Hyeok Seok · 2016 · The Journal of Immunology
89. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
    Peiwei Huangyang, Fuming Li, Pearl Lee, Itzhak Nissim, Aalim M. Weljie, Anthony Mancuso, Bo Li, Brian Keith, Sam S. Yoon, Marie Celeste Simon · 2019 · Cell Metabolism
90. Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
    Chi-hwa Wu, Debashis Sahoo, Constadina Arvanitis, Nicole Bradon, David L. Dill, Dean W. Felsher · 2008 · PLoS Genetics
91. Tumor‐suppressive micro RNA ‐135a inhibits cancer cell proliferation by targeting the c‐ MYC oncogene in renal cell carcinoma
    Yasutoshi Yamada, Hideo Hidaka, Naohiko Seki, Hirofumi Yoshino, Takeshi Yamasaki, Toshihiko Itesako, Masayuki Nakagawa, Hideki Enokida · 2012 · Cancer Science
92. Frequent Coamplification and Cooperation between C-MYC and PVT1 Oncogenes Promote Malignant Pleural Mesothelioma
    Erick Marcelo Riquelme, Milind B. Suraokar, Jaime Rodriguez‐Canales, Barbara Mino, Heather Yan Lin, David C. Rice, Anne S. Tsao, Ignacio Ivan Wistuba · 2014 · Journal of Thoracic Oncology
93. Genomic and Proteomic Analysis Reveals a Threshold Level of MYC Required for Tumor Maintenance
    Catherine M. Shachaf, Andrew J. Gentles, Sailaja V Elchuri, Debashis Sahoo, Yoav Soen, Orr Sharpe, Omar D. Perez, Maria Chang, Dennis Mitchel, William H. Robinson et al. · 2008 · Cancer Research
94. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
    Audrey Bouillez, Hasan N. Rajabi, Sean P. Pitroda, Caining Jin, Maroof Alam, Akriti Kharbanda, Ashujit Tagde, Kwok‐Kin Wong, Donald W. Kufe · 2016 · Cancer Research
95. Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1)
    Markus Hartl, Andrea Nist, M. Imran Khan, Taras Valovka, Klaus Bister · 2009 · Proceedings of the National Academy of Sciences
96. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
    Xuan J. Wang, Leonard Jeffrey Medeiros, Carlos Bueso-Ramos, Guilin Tang, Sa Wang, Yasuhiro Oki, Parth Anil Desai, Joseph David Khoury, Roberto N. Miranda, Zhenya Tang et al. · 2016 · Modern Pathology
97. Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway
    Ruzhen Zheng, Qinghua Deng, Yuehua Liu, Pengjun Zhao · 2017 · Medical Science Monitor
98. Altering chemosensitivity by modulating translation elongation
    Robert, Francis, Carrier, Marilyn, Rawe, Svea, Chen, Samuel, Lowe, Scott, Pelletier, Jerry · 2009 · PLoS ONE
99. The human papillomavirus E7 oncoprotein as a regulator of transcription
    William K. Songock, Seong‐Man Kim, Jason M. Bodily · 2016 · Virus Research
100. Max-independent functions of Myc in Drosophila melanogaster
     Dominik Steiger, Michael Furrer, Daniela Schwinkendorf, Peter Gallant · 2008 · Nature Genetics